10.3389/fphar.2018.01120 85 LiF
Both may support appetite control and weight loss, but the best option depends on your health history, lab work, and goals
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that mimics the hormone GLP-1
The SURMOUNT-5 trial, published in The New England Journal of Medicine , directly compared tirzepatide to semaglutide and found tirzepatide produced 47% greater relative weight loss at 72 weeks, 20.2% of body weight versus 13.7%
You might not lose 15% of your body weight in 6 months, but you can improve your health, feel more in control of your appetite, and yes, lose weight sustainably